The Office of Admissions recruits and matriculates those individuals most likely to enhance the overall health of our local, regional, national and international communities through the development of new knowledge and the provision of exemplary patient care. Each year, the School of Medicine matriculates a group of talented individuals who reflect the growing ethnic and cultural diversity of present day society, drawing on the knowledge and skills of individuals from all segments of society. Learn more about our Vision & Values.
Through innovative identification, recruitment and development programs, the School of Medicine has become recognized for the rich diversity of its student body. The Committee on Admissions has the daunting yet important job of selecting an outstanding entering freshman class each year from a bright, dedicated and diverse pool of applicants. The Committee will admit only those individuals who demonstrate the intellectual curiosity necessary for a lifetime of learning and who the Committee believes will maintain the highest standards of ethical and professional conduct.
Our students are our most prized asset and our dedicated faculty takes great joy and pride in helping each and every one of them develop into our future colleagues in the profession of medicine.
The University of Maryland, Baltimore is accredited by the Middle States Commission on Higher Education, 3624 Market St. Philadelphia, PA 19104
University of Maryland School of Medicine Launches Unprecedented Initiative to Recruit Scores of Top ScientistsUniversity of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, today announced the launch of a bold, new and unprecedented faculty recruitment initiative, Special Trans-Disciplinary Recruitment Award Program (STRAP), designed to attract top scientists to the School, and to significantly catalyze UM SOM’s focus on accelerating discoveries, cures and therapeutics for the most serious diseases that cause morbidity, mortality and disability.
University of Maryland School of Medicine Researchers Provide New Insight into Deadly Fungal InfectionsA new study by scientists at the University of Maryland School of Medicine has provided new, crucial insights into how little-known but life threatening fungal infections cause damage in the body. The study was published today in the journal Nature Communication. The researchers delineated several key aspects of the fungus that might help researchers develop treatments.
Researchers investigating a novel device to repair the mitral heart valve report 100 percent procedural success in a safety and performance study, the first such study done in humans. The image-guided device, based on technology developed at the University of Maryland School of Medicine, is deployed through a tiny opening in a beating heart, avoids open-heart surgery, automates a key part of the valve repair process, simplifies the procedure and reduces operating room time. The research is published in the journal Circulation.
William F. Regine, MD, FACR, FACRO, the Isadore & Fannie Foxman Schneider Endowed Chairman and Professor of Radiation Oncology at the University of Maryland School of Medicine (UM SOM) and the Executive Director of the Maryland Proton Treatment Center (MPTC), along with UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Charles B. Simone, II, MD, a nationally-recognized expert in proton therapy at the University of Pennsylvania, has been named the new Medical Director of the MPTC. Dr. Simone will also be appointed Associate Professor in the UM SOM Department of Radiation Oncology and will begin in his new position in November 2016.
Malaria is one of the world’s deadliest diseases: it infects hundreds of millions of people every year, and kills about half a million, most of them under five years of age.